Source:http://linkedlifedata.com/resource/pubmed/id/17301539
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2007-2-15
|
pubmed:abstractText |
We report a case of peritoneal cancer dissemination and cytological appearance of cancer cells with Type 4 gastric cancer. Treatment with unichemotherapy and combination chemotherapy with TS-1 proved successful. The patient was a 58-year-old female,who complained of abdominal pain. She was diagnosed as unresectable Type 4 gastric cancer, T 3 NxH 0 P 1 CY 1 M 0, Stage IV (cytology: Class V). Thirteen days after surgery, chemotherapy with TS-1 (80 mg/body/day, 4 weeks) at 2-week intervals in 1 course was performed. However, due to side effects with marrow restraint of grade 1, we changed to the following chemotherapy regimen: TS-1 (80 mg/body/day, 2 weeks) at 4-week intervals as 1 course (23 courses in total). After 16 courses, a partial response (PR) was noted. As additional therapy to recover tumor marker (CA19-9) after 21 courses, combination chemotherapy with TS-1 (80 mg/body/day, 2 weeks) and CDDP (25 mg/body/day, day 1, 8, 15 drip infusion) was performed as one course. This chemotherapy was then performed in 3 courses and tumor markers did not deteriorate, so we changed docetaxel (DOC) (50 mg/body/day(day 1)) to CDDP, and tumor markers returned to the normal value. No recurrence and no side effects appeared (hematological or non-hematological) during this combination chemotherapy.
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin,
http://linkedlifedata.com/resource/pubmed/chemical/Silicates,
http://linkedlifedata.com/resource/pubmed/chemical/Taxoids,
http://linkedlifedata.com/resource/pubmed/chemical/Titanium,
http://linkedlifedata.com/resource/pubmed/chemical/docetaxel,
http://linkedlifedata.com/resource/pubmed/chemical/titanium silicide
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0385-0684
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
257-60
|
pubmed:meshHeading |
pubmed-meshheading:17301539-Adenocarcinoma,
pubmed-meshheading:17301539-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17301539-Cisplatin,
pubmed-meshheading:17301539-Drug Administration Schedule,
pubmed-meshheading:17301539-Female,
pubmed-meshheading:17301539-Humans,
pubmed-meshheading:17301539-Middle Aged,
pubmed-meshheading:17301539-Peritoneal Neoplasms,
pubmed-meshheading:17301539-Quality of Life,
pubmed-meshheading:17301539-Silicates,
pubmed-meshheading:17301539-Stomach Neoplasms,
pubmed-meshheading:17301539-Survivors,
pubmed-meshheading:17301539-Taxoids,
pubmed-meshheading:17301539-Titanium
|
pubmed:year |
2007
|
pubmed:articleTitle |
[Long survival and effective treatment of unresectable gastric cancer by TS-1 based chemotherapy with a sequential combination].
|
pubmed:affiliation |
The Third Dept. of Surgery, Tokyo Medical University.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Case Reports
|